cells Article iPS-Derived Early Oligodendrocyte Progenitor Cells from SPMS Patients Reveal Deficient In Vitro Cell Migration Stimulation Lidia Lopez-Caraballo 1, Jordi Martorell-Marugan 2,3 , Pedro Carmona-Sáez 2,4 and Elena Gonzalez-Munoz 1,5,6,* 1 Laboratory of Cell Reprogramming (LARCEL), Andalusian Centre for Nanomedicine and Biotechnology-BIONAND, 29590 Málaga, Spain;
[email protected] 2 Bioinformatics Unit. GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, E-18016 Granada, Spain;
[email protected] (J.M.-M.);
[email protected] (P.C.-S.) 3 Atrys Health, 08025 Barcelona, Spain 4 Department of Statistics. University of Granada, 18071 Granada, Spain 5 Department of Cell Biology, Genetics and Physiology, University of Málaga, 29071 Málaga, Spain 6 Networking Research Center on Bioengineering, Biomaterials and Nanomedicine, (CIBER-BBN), 29071 Málaga, Spain * Correspondence:
[email protected]; Tel.: +34-952367616 Received: 18 June 2020; Accepted: 28 July 2020; Published: 29 July 2020 Abstract: The most challenging aspect of secondary progressive multiple sclerosis (SPMS) is the lack of efficient regenerative response for remyelination, which is carried out by the endogenous population of adult oligoprogenitor cells (OPCs) after proper activation. OPCs must proliferate and migrate to the lesion and then differentiate into mature oligodendrocytes. To investigate the OPC cellular component in SPMS, we developed induced pluripotent stem cells (iPSCs) from SPMS-affected donors and age-matched controls (CT). We confirmed their efficient and similar OPC differentiation capacity, although we reported SPMS-OPCs were transcriptionally distinguishable from their CT counterparts. Analysis of OPC-generated conditioned media (CM) also evinced differences in protein secretion.